Primary Site >> Stomach Cancer
Gene >> MAD2L1
| 1. | |||||||||||
| Journal: | Jpn J Cancer Res. 2001 Sep;92(9):952-8. | ||||||||||
| Title: | Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers. | ||||||||||
| Author: | Tanaka, K|Nishioka, J|Kato, K|Nakamura, A|Mouri, T|Miki, C|Kusunoki, M|Nobori, T | ||||||||||
| PMID: | 11572763 | ||||||||||
| 2. | |||||||||||
| Journal: | Zhonghua Zhong Liu Za Zhi. 2004 Apr;26(4):201-4. | ||||||||||
| Title: | [Multidrug resistant effect of alternative splicing form of MAD2 gene-MAD2beta on human gastric cancer cell]. | ||||||||||
| Author: | Yin, Fang|Hu, Wen-hua|Qiao, Tai-dong|Fan, Dai-ming | ||||||||||
| PMID: | 15312379 | ||||||||||
| 3. | |||||||||||
| Journal: | World J Gastroenterol. 2004 Nov 15;10(22):3240-4. | ||||||||||
| Title: | Elevated level of spindle checkprotein MAD2 correlates with cellular mitotic arrest, but not with aneuploidy and clinicopathological characteristics in gastric cancer. | ||||||||||
| Author: | Wu, Chew-Wun|Chi, Chin-Wen|Huang, Tze-Sing | ||||||||||
| PMID: | 15484292 | ||||||||||
| 4. | |||||||||||
| Journal: | Mutat Res. 2005 Oct 15;578(1-2):187-201. | ||||||||||
| Title: | Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint. | ||||||||||
| Author: | Kim, Han-Soo|Park, Kyung Hwa|Kim, Sun A|Wen, Jing|Park, Seung Woo|Park, Byungkyu|Gham, Chang-Woo|Hyung, Woo Jin|Noh, Sung Hoon|Kim, Ho Kun|Song, Si Young | ||||||||||
| PMID: | 16112690 | ||||||||||
| 5. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2006 Feb;57(3):368-75. | ||||||||||
| Title: | Administration sequence-dependent antitumor effects of paclitaxel and 5-fluorouracil in the human gastric cancer cell line MKN45. | ||||||||||
| Author: | Toiyama, Yuji|Tanaka, Koji|Konishi, Naomi|Mohri, Yasuhiko|Tonouchi, Hitoshi|Miki, Chikao|Kusunoki, Masato | ||||||||||
| PMID: | 16075279 | ||||||||||
| 6. | |||||||||||
| Journal: | Life Sci. 2006 Feb 16;78(12):1277-86. | ||||||||||
| Title: | Mad2beta, an alternative variant of Mad2 reducing mitotic arrest and apoptosis induced by adriamycin in gastric cancer cells. | ||||||||||
| Author: | Yin, Fang|Du, Yulei|Hu, Wenhua|Qiao, Taidong|Ding, Jie|Wu, Kaichun|Liu, Zhiguo|Fan, Daiming | ||||||||||
| PMID: | 16214181 | ||||||||||
| 7. | |||||||||||
| Journal: | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 May;22(3):290-2. | ||||||||||
| Title: | [Construction of eukaryotic expression vector of siRNA specific for MAD2 and its effect on the growth of gastric cell line SGC7901]. | ||||||||||
| Author: | Du, Yu-lei|Yin, Fang|Yang, Gui-tao|Xie, Hua-hong|Song, Jiu-gang|Liu, Jie|Fan, Dai-ming | ||||||||||
| PMID: | 16643781 | ||||||||||
| 8. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2006 Jul 7;345(3):1092-8. Epub 2006 May 8. | ||||||||||
| Title: | Depression of MAD2 inhibits apoptosis of gastric cancer cells by upregulating Bcl-2 and interfering mitochondrion pathway. | ||||||||||
| Author: | Du, Yulei|Yin, Fang|Liu, Changjiang|Hu, Shengjuan|Wang, Jun|Xie, Huahong|Hong, Liu|Fan, Daiming | ||||||||||
| PMID: | 16714000 | ||||||||||
| 9. | |||||||||||
| Journal: | Am J Clin Pathol. 2009 Jun;131(6):793-801. | ||||||||||
| Title: | MAD2 as a key component of mitotic checkpoint: A probable prognostic factor for gastric cancer. | ||||||||||
| Author: | Wang, Li|Yin, Fang|Du, Yulei|Du, Wenqi|Chen, Bei|Zhang, Yongguo|Wu, Kaichun|Ding, Jie|Liu, Jie|Fan, Daiming | ||||||||||
| PMID: | 19461085 | ||||||||||
| 10. | |||||||||||
| Journal: | Mol Med Rep. 2009 Jul-Aug;2(4):589-96. | ||||||||||
| Title: | BubR1 and AURKB overexpression are associated with a favorable prognosis in gastric cancer. | ||||||||||
| Author: | Enjoji, Megumu|Iida, Satoru|Sugita, Hirofumi|Ishikawa, Toshiaki|Uetake, Hiroyuki|Inokuchi, Mikito|Yamada, Hiroyuki|Kojima, Kazuyuki|Sugihara, Kenichi | ||||||||||
| PMID: | 21475871 | ||||||||||
| 11. | |||||||||||
| Journal: | Tumour Biol. 2010 Jun;31(3):225-32. | ||||||||||
| Title: | Depression of MAD2 inhibits apoptosis and increases proliferation and multidrug resistance in gastric cancer cells by regulating the activation of phosphorylated survivin. | ||||||||||
| Author: | Wang, Li|Yin, Fang|Du, Yulei|Chen, Bei|Liang, Shuhui|Zhang, Yongguo|Du, Wenqi|Wu, Kaichun|Ding, Jie|Fan, Daiming | ||||||||||
| PMID: | 20440596 | ||||||||||
| 12. | |||||||||||
| Journal: | Cancer Med. 2013 Aug;2(4):447-56. | ||||||||||
| Title: | Contribution of BubR1 to oxidative stress-induced aneuploidy in p53-deficient cells. | ||||||||||
| Author: | Ikawa-Yoshida, Ayae|Ando, Koji|Oki, Eiji|Saeki, Hiroshi|Kumashiro, Ryuichi|Taketani, Kenji|Ida, Satoshi|Tokunaga, Eriko|Kitao, Hiroyuki|Morita, Masaru|Maehara, Yoshihiko | ||||||||||
| PMID: | 24156017 | ||||||||||
| 13. | |||||||||||
| Journal: | Cell Biol Int. 2014 Apr;38(4):502-10. | ||||||||||
| Title: | PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line. | ||||||||||
| Author: | Tang, Tao|Song, Xin|Liu, Yu-Fen|Wang, Wen-Yue | ||||||||||
| PMID: | 23956061 | ||||||||||
| 14. | |||||||||||
| Journal: | Cell Cycle. 2014;13(22):3590-601. | ||||||||||
| Title: | Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells. | ||||||||||
| Author: | Bargiela-Iparraguirre, J|Prado-Marchal, L|Pajuelo-Lozano, N|Jimenez, B|Perona, R|Sanchez-Perez, I | ||||||||||
| PMID: | 25483095 | ||||||||||
| 15. | |||||||||||
| Journal: | Int J Biochem Cell Biol. 2016 Oct;79:451-461. | ||||||||||
| Title: | The ubiquitin-like modifier FAT10 in cancer development. | ||||||||||
| Author: | Aichem, Annette|Groettrup, Marcus | ||||||||||
| PMID: | 27393295 | ||||||||||
| 16. | |||||||||||
| Journal: | Nan Fang Yi Ke Da Xue Xue Bao. 2018 Sep 30;38(10):1151-1158. | ||||||||||
| Title: | [Screening of cell cycle-related genes regulated by KIAA0101 in gastric cancer]. | ||||||||||
| Author: | Wang, Zhi|Dang, Chengxue|Yan, Rong|Zhang, Hao|Yuan, Dawei|Li, Kang | ||||||||||
| PMID: | 30377125 | ||||||||||